GlobeNewswire by notified

CSC and Intertrust have obtained Regulatory Clearance for Intertrust’s payment institution in the Netherlands

Share

JOINT PRESS RELEASE

This is a joint press release by Intertrust N.V. ("Intertrust" or the "Company") and CSC (Netherlands) Holdings B.V. ("CSC" or the "Offeror") in connection with the recommended public offer (the "Offer") by the Offeror for all the issued and outstanding ordinary shares in the capital of Intertrust. This announcement does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in Intertrust. Any offer will be made only by means of the offer memorandum (the "Offer Memorandum") approved by the Dutch Authority for Financial Markets (Stichting Autoriteit Financiële Markten, the "AFM") which was published on 31 March 2022, and subject to the restrictions set forth therein. With reference to the joint press releases of 6 December 2021, 31 March 2022, 30 May 2022, 21 July 2022, and the Intertrust press release of 31 May 2022, the Offer is subject to the satisfaction or waiver of the offer conditions, all in accordance with the terms of the merger agreement (the "Merger Agreement") between Intertrust and Corporation Service Company as executed on 6 December 2021 and the Offer Memorandum (the "Offer Conditions"). The offer price of EUR 20.00 per Share (the "Offer Price") is "cum dividend". This announcement is not for release, publication or distribution, in whole or in part, in or into, directly or indirectly, Canada and Japan or any other jurisdiction in which such release, publication or distribution would be unlawful. Capitalised terms used herein but not defined in this press release will have the meaning as ascribed thereto in the Offer.

CSC and Intertrust have obtained Regulatory Clearance for Intertrust’s payment institution in the Netherlands

Wilmington, Delaware, USA / Amsterdam, the Netherlands – 30 August 2022 – CSC and Intertrust hereby jointly announce that Regulatory Clearance has been obtained for Intertrust’s payment institution (betaalinstelling) in the Netherlands.CSC and Intertrust are awaiting two remaining approvals in the Netherlands, being the Regulatory Clearance for each of Intertrust’s trust offices (trustkantoor)from the Dutch Central Bank (De Nederlandse Bank) and Regulatory Clearance for Intertrust’s depositary (bewaarder)from the Dutch Authority for the Financial Markets (Autoriteit Financiële Markten).

Reference is made to the joint press release issued by CSC and Intertrust on 31 March 2022 in respect of the publication of the Offer Memorandum for the recommended all-cash public offer by the Offeror for all issued and outstanding shares in the capital of Intertrust at an offer price of EUR 20.00 (cum dividend), on the terms and subject to the conditions and restrictions set forth in the Offer Memorandum, and the joint press release issued by CSC and Intertrust on 21 July 2022 in relation to the further extension of the extended Offer Period, pursuant to an exemption granted by the AFM on 21 July 2022, until the earlier of (i) the date on which all Regulatory Clearances have been obtained or waived, plus a period of two weeks, or (ii) 6 December 2022, at 17:40 CET.

Regulatory Clearances status
CSC and Intertrust have obtained all Regulatory Clearances in 8 of the required 13 jurisdictions (the British Virgin Islands, Curaçao, Guernsey, Hong Kong, Jersey, Singapore, the United Arab Emirates and the United Kingdom) and partial Regulatory Clearance in Luxembourg and the Netherlands. CSC and Intertrust continue to work constructively to satisfy all Offer Conditions.

At the date of this press release, CSC and Intertrust have not yet received all Regulatory Clearances in the following jurisdictions: the Bahamas, the Cayman Islands, Ireland, Luxembourg, and the Netherlands. At this time, CSC and Intertrust continue to anticipate that the Offer will close in the second half of 2022.

Further announcements

CSC and Intertrust will make a public announcement (i) promptly following the receipt of each remaining Regulatory Clearance, (ii) if and when the Offer Condition with respect to the Regulatory Clearances is satisfied, waived or has become incapable of being satisfied, or (iii) as otherwise required by applicable law. The announcement that the Offer Condition with respect to the Regulatory Clearances would have been satisfied or waived, if made, will include the end date of the Offer Period, which will be two weeks following the date such Offer Condition is fulfilled, subject to the end date of 6 December 2022, at 17:40 CET.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

ABG Sundal Collier Initiates Coverage of CoinShares International Limited8.5.2024 15:21:20 CEST | Press release

8th May 2024 | SAINT HELIER, Jersey | CoinShares International Limited (“CoinShares'' or “the Group”) (Nasdaq Stockholm: CS; US OTCQX: CNSRF), the leading European investment company specialising in digital assets, is pleased to announce that ABG Sundal Collier has initiated coverage of the Company. Click here to view the full report or here to download the report. ABOUT COINSHARES CoinShares is the leading European investment company specialising in digital assets, that delivers a broad range of financial services across investment management, trading and securities to a wide array of clients that includes corporations, financial institutions and individuals. Focusing on crypto since 2013, the firm is headquartered in Jersey, with offices in France, Sweden, Switzerland, the UK and the US. CoinShares is regulated in Jersey by the Jersey Financial Services Commission, in France by the Autorité des marchés financiers, and in the US by the Financial Industry Regulatory Authority. CoinShar

Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S8.5.2024 15:16:55 CEST | Press release

8 May 2024 Announcement No. 16 Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S In continuation of company announcement no. 15 of 8 May 2024 regarding notice of an extraordinary general meeting, to be held on 3 June 2024. with a view to reducing the company's capital, the Board of Directors of Pharma Equity Group A/S ("PEG") has today decided to explore the possibilities of strengthening PEG's working capital through a capital increase at market price. Any directed capital increase will be expected to be carried out without a prospectus being prepared due to the expected size of the capital increase. Any capital increase will be subject to the adoption of the capital reduction. The specific details of a possible capital increase will be published when and if the Board of Directors decides to do so. For further information, please contact: Thomas Kaas Selsø, CEO of Pharma Equity Group A/S, phone: +45 4022 2114 Christian Vinding Thom

Afsøgning af muligheder angående en rettet kapitalforhøjelse til markedskurs i Pharma Equity Group A/S8.5.2024 15:16:55 CEST | pressemeddelelse

8. maj 2024 Meddelelse nr. 16 Afsøgning af muligheder angående en rettet kapitalforhøjelse til markedskurs i Pharma Equity Group A/S I forlængelse af selskabsmeddelelse nr. 15 fra 8. maj 2024 angående indkaldelse til en ekstraordinær generalforsamling den 3. juni 2024 med henblik på at nedsætte selskabets kapital, har bestyrelsen i Pharma Equity Group A/S ("PEG") i dag truffet beslutning om at afsøge mulighederne for at styrke PEG's arbejdskapital ved en kapitalforhøjelse til markedspris. En eventuel rettet kapitalforhøjelse vil forventeligt blive gennemført uden, at der udarbejdes et prospekt grundet kapitalforhøjelses forventede størrelse. En eventuel kapitalforhøjelse vil forudsætte, at kapitalnedsættelsen vedtages. De konkrete detaljer omkring en eventuel kapitalforhøjelse vil blive offentliggjort når og hvis bestyrelsen måtte træffe beslutning herom. For yderligere information, kontakt venligst: Thomas Kaas Selsø, adm. direktør i Pharma Equity Group A/S, telefon: +45 4022 2114 Chr

Standard Lithium and Equinor Form Partnership to Develop South West Arkansas and East Texas Lithium Projects8.5.2024 14:00:00 CEST | Press release

Equinor Commits to Contribute up to a US$160 million Gross Investment for a 45% interest in two special purpose entities with SLI to develop a sustainable lithium business in the United States VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today announced the closing of a landmark strategic partnership (the “Transaction”) with Equinor ASA (NYSE: EQNR), a multinational energy company and recognized leader in renewables and low-carbon solutions, to accelerate the development of Standard Lithium’s large-scale, sustainable lithium projects in the Smackover Formation. The Transaction includes Equinor's contribution of up to US$160 million, representing its total gross project-level investment and reflecting its 45% ownership stake in the two entities. This investment includes a US$30 million cash payment to Standard Lithi

HiddenA line styled icon from Orion Icon Library.Eye